Home  /  Covid-19

This is the first pharmaceutical Rapid Collaborative Review (PTRCR15) for – Remdesivir for the treatment of COVID-19. PICO and Evidence gaps.In June, 2020, the European Commission granted marketing authorisation for Veklury® (remdesivir) for the treatment of Covid-19. This Rapid Collaborative Review aims

EUnetHTA is pleased to announce the publication of the final project plan of its Rapid Collaborative Review on the diagnostic accuracy of molecular methods that detect the presence of SARS-CoV-2 virus in people with suspected COVID-19.This is the second one of

EUnetHTA is pleased to announce that the "Rapid Collaborative Review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic" is now available.  This is the first rapid review assessing health technologies for